ID   RAP1B_HUMAN             Reviewed;         184 AA.
AC   P61224; B2R5Z2; B4DQI8; B4DW74; B4DW94; P09526; Q502X3; Q5TZR4;
AC   Q6DCA1; Q6LES0;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 1.
DT   22-JUL-2015, entry version 138.
DE   RecName: Full=Ras-related protein Rap-1b;
DE   AltName: Full=GTP-binding protein smg p21B;
DE   Flags: Precursor;
GN   Name=RAP1B; ORFNames=OK/SW-cl.11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3137530; DOI=10.1093/nar/16.15.7719;
RA   Pizon V., Lerosey I., Chardin P., Tavitian A.;
RT   "Nucleotide sequence of a human cDNA encoding a ras-related protein
RT   (rap1B).";
RL   Nucleic Acids Res. 16:7719-7719(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Chondrosarcoma, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-35, SUBCELLULAR LOCATION, AND ADP-RIBOSYLATION
RP   AT SER-39.
RX   PubMed=3141412;
RA   Bokoch G.M., Parkos C.A., Mumby S.M.;
RT   "Purification and characterization of the 22,000-dalton GTP-binding
RT   protein substrate for ADP-ribosylation by botulinum toxin, G22K.";
RL   J. Biol. Chem. 263:16744-16749(1988).
RN   [13]
RP   PROTEIN SEQUENCE OF 146-180, AND PHOSPHORYLATION.
RX   PubMed=1696481; DOI=10.1016/0006-291X(90)92182-Y;
RA   Siess W., Winegar D.A., Lapetina E.G.;
RT   "Rap1-B is phosphorylated by protein kinase A in intact human
RT   platelets.";
RL   Biochem. Biophys. Res. Commun. 170:944-950(1990).
RN   [14]
RP   PROTEIN SEQUENCE OF 168-176.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [15]
RP   ISOPRENYLATION AT CYS-181, AND METHYLATION AT CYS-181.
RC   TISSUE=Platelet;
RX   PubMed=2123345; DOI=10.1073/pnas.87.22.8960;
RA   Kawata M., Farnsworth C.C., Yoshida Y., Gelb M.H., Glomset J.A.,
RA   Takai Y.;
RT   "Posttranslationally processed structure of the human platelet protein
RT   smg p21B: evidence for geranylgeranylation and carboxyl methylation of
RT   the C-terminal cysteine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8960-8964(1990).
RN   [16]
RP   PHOSPHORYLATION AT SER-179 BY PKA, AND MUTAGENESIS OF SER-179.
RX   PubMed=8463283;
RA   Altschuler D., Lapetina E.G.;
RT   "Mutational analysis of the cAMP-dependent protein kinase-mediated
RT   phosphorylation site of Rap1b.";
RL   J. Biol. Chem. 268:7527-7531(1993).
RN   [17]
RP   INTERACTION WITH SGSM1; SGSM2 AND SGSM3.
RX   PubMed=17509819; DOI=10.1016/j.ygeno.2007.03.013;
RA   Yang H., Sasaki T., Minoshima S., Shimizu N.;
RT   "Identification of three novel proteins (SGSM1, 2, 3) which modulate
RT   small G protein (RAP and RAB)-mediated signaling pathway.";
RL   Genomics 90:249-260(2007).
RN   [18]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20332120; DOI=10.1242/jcs.059329;
RA   Lampugnani M.G., Orsenigo F., Rudini N., Maddaluno L., Boulday G.,
RA   Chapon F., Dejana E.;
RT   "CCM1 regulates vascular-lumen organization by inducing endothelial
RT   polarity.";
RL   J. Cell Sci. 123:1073-1080(2010).
RN   [19]
RP   FUNCTION.
RX   PubMed=21840392; DOI=10.1016/j.cellsig.2011.07.022;
RA   Pannekoek W.J., van Dijk J.J., Chan O.Y., Huveneers S.,
RA   Linnemann J.R., Spanjaard E., Brouwer P.M., van der Meer A.J.,
RA   Zwartkruis F.J., Rehmann H., de Rooij J., Bos J.L.;
RT   "Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction
RT   control.";
RL   Cell. Signal. 23:2056-2064(2011).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 1-167 IN COMPLEX WITH GTP
RP   ANALOG AND RAP1GAP, SUBUNIT, ENZYME REGULATION, AND MUTAGENESIS OF
RP   TYR-32; GLN-63 AND PHE-64.
RX   PubMed=18309292; DOI=10.1038/emboj.2008.30;
RA   Scrima A., Thomas C., Deaconescu D., Wittinghofer A.;
RT   "The Rap-RapGAP complex: GTP hydrolysis without catalytic glutamine
RT   and arginine residues.";
RL   EMBO J. 27:1145-1153(2008).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-167 IN COMPLEX WITH EPAC2,
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF GLU-37.
RX   PubMed=18660803; DOI=10.1038/nature07187;
RA   Rehmann H., Arias-Palomo E., Hadders M.A., Schwede F., Llorca O.,
RA   Bos J.L.;
RT   "Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B.";
RL   Nature 455:124-127(2008).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 1-167 OF MUTANT VAL-12 IN
RP   COMPLEX WITH KRIT1; GTP ANALOG AND MAGNESIUM, AND INTERACTION WITH
RP   KRIT1.
RX   PubMed=22577140; DOI=10.1074/jbc.M112.361295;
RA   Li X., Zhang R., Draheim K.M., Liu W., Calderwood D.A., Boggon T.J.;
RT   "Structural basis for small G protein effector interaction of Ras-
RT   related protein 1 (Rap1) and adaptor protein Krev interaction trapped
RT   1 (KRIT1).";
RL   J. Biol. Chem. 287:22317-22327(2012).
CC   -!- FUNCTION: GTP-binding protein that possesses intrinsic GTPase
CC       activity. Contributes to the polarizing activity of KRIT1 and CDH5
CC       in the establishment and maintenance of correct endothelial cell
CC       polarity and vascular lumen. Required for the localization of
CC       phosphorylated PRKCZ, PARD3 and TIAM1 to the cell junction. Plays
CC       a role in the establishment of basal endothelial barrier function.
CC       {ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:20332120,
CC       ECO:0000269|PubMed:21840392}.
CC   -!- ENZYME REGULATION: Activated by binding to the GTPase-activating
CC       protein RAP1GAP. Activated by guanine nucleotide-exchange factor
CC       (GEF) EPAC2 in a cAMP-dependent manner.
CC       {ECO:0000269|PubMed:18309292}.
CC   -!- SUBUNIT: Heterodimer with RAP1GAP. Interacts with EPAC2, SGSM1,
CC       SGSM2 and SGSM3. Interacts with KRIT1.
CC       {ECO:0000269|PubMed:17509819, ECO:0000269|PubMed:18309292,
CC       ECO:0000269|PubMed:18660803, ECO:0000269|PubMed:22577140}.
CC   -!- INTERACTION:
CC       Q12967:RALGDS; NbExp=2; IntAct=EBI-358143, EBI-365861;
CC       P47736:RAP1GAP; NbExp=3; IntAct=EBI-358143, EBI-722307;
CC       Q8WWW0:RASSF5; NbExp=3; IntAct=EBI-358143, EBI-367390;
CC       P0CG48:UBC; NbExp=2; IntAct=EBI-358143, EBI-3390054;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Cytoplasm, cytosol. Cell
CC       junction. Note=May shuttle between plasma membrane and cytosol.
CC       Presence of KRIT1 and CDH5 is required for its localization to the
CC       cell junction.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P61224-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P61224-2; Sequence=VSP_045305;
CC       Name=3;
CC         IsoId=P61224-3; Sequence=VSP_045304;
CC       Name=4;
CC         IsoId=P61224-4; Sequence=VSP_045303;
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Ras family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RAP1BID273.html";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/rap1b/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X08004; CAB46488.1; -; mRNA.
DR   EMBL; AL080212; CAB45777.1; -; mRNA.
DR   EMBL; AB062128; BAB93460.1; -; mRNA.
DR   EMBL; AF493913; AAM12627.1; -; mRNA.
DR   EMBL; AK298818; BAG60950.1; -; mRNA.
DR   EMBL; AK301401; BAG62936.1; -; mRNA.
DR   EMBL; AK301428; BAG62956.1; -; mRNA.
DR   EMBL; AK312371; BAG35289.1; -; mRNA.
DR   EMBL; CR407689; CAG28617.1; -; mRNA.
DR   EMBL; BT020093; AAV38896.1; -; mRNA.
DR   EMBL; EF581377; ABQ52130.1; -; Genomic_DNA.
DR   EMBL; AC015550; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97189.1; -; Genomic_DNA.
DR   EMBL; BC000176; AAH00176.1; -; mRNA.
DR   EMBL; BC078173; AAH78173.1; -; mRNA.
DR   EMBL; BC095467; AAH95467.1; -; mRNA.
DR   CCDS; CCDS58252.1; -. [P61224-2]
DR   CCDS; CCDS58253.1; -. [P61224-3]
DR   CCDS; CCDS58254.1; -. [P61224-4]
DR   CCDS; CCDS8984.1; -. [P61224-1]
DR   PIR; S01952; TVHUR1.
DR   RefSeq; NP_001010942.1; NM_001010942.2. [P61224-1]
DR   RefSeq; NP_001238846.1; NM_001251917.1. [P61224-4]
DR   RefSeq; NP_001238847.1; NM_001251918.1. [P61224-4]
DR   RefSeq; NP_001238850.1; NM_001251921.1. [P61224-3]
DR   RefSeq; NP_001238851.1; NM_001251922.1. [P61224-2]
DR   RefSeq; NP_056461.1; NM_015646.5. [P61224-1]
DR   UniGene; Hs.369920; -.
DR   PDB; 3BRW; X-ray; 3.40 A; D=1-167.
DR   PDB; 3CF6; X-ray; 2.20 A; R=1-167.
DR   PDB; 4DXA; X-ray; 1.95 A; A=1-167.
DR   PDB; 4HDO; X-ray; 1.67 A; B=1-167.
DR   PDB; 4HDQ; X-ray; 1.95 A; B=1-167.
DR   PDB; 4M8N; X-ray; 3.29 A; E/F/G/H=1-166.
DR   PDB; 4MGI; X-ray; 2.80 A; R=1-167.
DR   PDB; 4MGK; X-ray; 2.70 A; R=1-167.
DR   PDB; 4MGY; X-ray; 2.60 A; R=1-167.
DR   PDB; 4MGZ; X-ray; 3.00 A; R=1-167.
DR   PDB; 4MH0; X-ray; 2.40 A; R=1-167.
DR   PDBsum; 3BRW; -.
DR   PDBsum; 3CF6; -.
DR   PDBsum; 4DXA; -.
DR   PDBsum; 4HDO; -.
DR   PDBsum; 4HDQ; -.
DR   PDBsum; 4M8N; -.
DR   PDBsum; 4MGI; -.
DR   PDBsum; 4MGK; -.
DR   PDBsum; 4MGY; -.
DR   PDBsum; 4MGZ; -.
DR   PDBsum; 4MH0; -.
DR   ProteinModelPortal; P61224; -.
DR   SMR; P61224; 1-166.
DR   BioGrid; 111843; 45.
DR   DIP; DIP-35407N; -.
DR   IntAct; P61224; 32.
DR   MINT; MINT-1133272; -.
DR   STRING; 9606.ENSP00000250559; -.
DR   PhosphoSite; P61224; -.
DR   BioMuta; RAP1B; -.
DR   DMDM; 47117723; -.
DR   OGP; P09526; -.
DR   MaxQB; P61224; -.
DR   PaxDb; P61224; -.
DR   PRIDE; P61224; -.
DR   DNASU; 5908; -.
DR   Ensembl; ENST00000250559; ENSP00000250559; ENSG00000127314.
DR   Ensembl; ENST00000341355; ENSP00000441275; ENSG00000127314.
DR   Ensembl; ENST00000393436; ENSP00000377085; ENSG00000127314.
DR   Ensembl; ENST00000450214; ENSP00000399986; ENSG00000127314. [P61224-4]
DR   Ensembl; ENST00000537460; ENSP00000439966; ENSG00000127314.
DR   Ensembl; ENST00000539091; ENSP00000444830; ENSG00000127314. [P61224-4]
DR   Ensembl; ENST00000540209; ENSP00000446318; ENSG00000127314. [P61224-3]
DR   Ensembl; ENST00000542145; ENSP00000440014; ENSG00000127314. [P61224-2]
DR   GeneID; 5908; -.
DR   KEGG; hsa:5908; -.
DR   UCSC; uc001sub.3; human. [P61224-1]
DR   UCSC; uc010stf.2; human.
DR   UCSC; uc010stg.2; human.
DR   UCSC; uc010sti.2; human.
DR   CTD; 5908; -.
DR   GeneCards; GC12P069005; -.
DR   H-InvDB; HIX0032084; -.
DR   HGNC; HGNC:9857; RAP1B.
DR   MIM; 179530; gene.
DR   neXtProt; NX_P61224; -.
DR   PharmGKB; PA34219; -.
DR   eggNOG; COG1100; -.
DR   GeneTree; ENSGT00780000121857; -.
DR   HOGENOM; HOG000233973; -.
DR   HOVERGEN; HBG009351; -.
DR   InParanoid; P61224; -.
DR   KO; K07836; -.
DR   OMA; RDSTHPR; -.
DR   OrthoDB; EOG7QVM41; -.
DR   PhylomeDB; P61224; -.
DR   TreeFam; TF313014; -.
DR   Reactome; REACT_15381; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; REACT_15443; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; REACT_15523; Integrin alphaIIb beta3 signaling.
DR   Reactome; REACT_23898; Rap1 signalling.
DR   SignaLink; P61224; -.
DR   ChiTaRS; RAP1B; human.
DR   EvolutionaryTrace; P61224; -.
DR   GeneWiki; RAP1B; -.
DR   GenomeRNAi; 5908; -.
DR   NextBio; 22980; -.
DR   PRO; PR:P61224; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; P61224; -.
DR   CleanEx; HS_RAP1B; -.
DR   ExpressionAtlas; P61224; baseline and differential.
DR   Genevisible; P61224; HS.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0005811; C:lipid particle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0019003; F:GDP binding; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IDA:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IDA:MGI.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB.
DR   GO; GO:0008152; P:metabolic process; IDA:GOC.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IEA:Ensembl.
DR   GO; GO:2000301; P:negative regulation of synaptic vesicle exocytosis; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0032486; P:Rap protein signal transduction; IMP:UniProtKB.
DR   GO; GO:1901888; P:regulation of cell junction assembly; IMP:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; IMP:UniProtKB.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   InterPro; IPR020849; Small_GTPase_Ras.
DR   PANTHER; PTHR24070; PTHR24070; 1.
DR   Pfam; PF00071; Ras; 1.
DR   PRINTS; PR00449; RASTRNSFRMNG.
DR   SMART; SM00173; RAS; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51421; RAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Alternative splicing; Cell junction;
KW   Cell membrane; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; GTP-binding; Lipoprotein; Membrane;
KW   Methylation; Nucleotide-binding; Phosphoprotein; Prenylation;
KW   Reference proteome.
FT   CHAIN         1    181       Ras-related protein Rap-1b.
FT                                /FTId=PRO_0000030209.
FT   PROPEP      182    184       Removed in mature form.
FT                                /FTId=PRO_0000030210.
FT   NP_BIND      10     18       GTP. {ECO:0000269|PubMed:18309292,
FT                                ECO:0000269|PubMed:22577140}.
FT   NP_BIND      57     61       GTP. {ECO:0000269|PubMed:18309292,
FT                                ECO:0000269|PubMed:22577140}.
FT   NP_BIND     116    119       GTP. {ECO:0000269|PubMed:18309292,
FT                                ECO:0000269|PubMed:22577140}.
FT   NP_BIND     147    149       GTP. {ECO:0000269|PubMed:18309292,
FT                                ECO:0000269|PubMed:22577140}.
FT   REGION       25     67       Interaction with KRIT1.
FT   MOTIF        32     40       Effector region. {ECO:0000305}.
FT   MOD_RES      39     39       ADP-ribosylserine; by botulinum toxin.
FT                                {ECO:0000305|PubMed:3141412}.
FT   MOD_RES     179    179       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:8463283}.
FT   MOD_RES     181    181       Cysteine methyl ester.
FT                                {ECO:0000269|PubMed:2123345}.
FT   LIPID       181    181       S-geranylgeranyl cysteine.
FT                                {ECO:0000269|PubMed:2123345}.
FT   VAR_SEQ      20     61       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045303.
FT   VAR_SEQ      43     61       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045304.
FT   VAR_SEQ      62    108       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045305.
FT   MUTAGEN      12     12       G->V: Constitutively activated.
FT   MUTAGEN      25     25       Q->A: Impairs interaction with KRIT1.
FT   MUTAGEN      32     32       Y->A: 25-fold reduction in RAP1GAP-
FT                                stimulated GTPase activity.
FT                                {ECO:0000269|PubMed:18309292}.
FT   MUTAGEN      32     32       Y->F: 2-fold reduction in RAP1GAP-
FT                                stimulated GTPase activity.
FT                                {ECO:0000269|PubMed:18309292}.
FT   MUTAGEN      37     37       E->A: Strong reduction in nucleotide
FT                                exchange with EPAC2.
FT                                {ECO:0000269|PubMed:18660803}.
FT   MUTAGEN      38     38       D->A: Impairs interaction with KRIT1.
FT   MUTAGEN      63     63       Q->E: Abolishes complex formation with
FT                                RAP1GAP. Loss GTPase activity.
FT                                {ECO:0000269|PubMed:18309292}.
FT   MUTAGEN      64     64       F->A: Abolishes complex formation with
FT                                RAP1GAP. Loss GTPase activity.
FT                                {ECO:0000269|PubMed:18309292}.
FT   MUTAGEN     179    179       S->A: Abolishes phosphorylation by PKA.
FT                                {ECO:0000269|PubMed:8463283}.
FT   CONFLICT      8      8       V -> F (in Ref. 11; AAH95467).
FT                                {ECO:0000305}.
FT   CONFLICT     16     16       K -> N (in Ref. 11; AAH78173).
FT                                {ECO:0000305}.
FT   STRAND        2      9       {ECO:0000244|PDB:4HDO}.
FT   HELIX        16     25       {ECO:0000244|PDB:4HDO}.
FT   TURN         27     29       {ECO:0000244|PDB:3CF6}.
FT   STRAND       36     46       {ECO:0000244|PDB:4HDO}.
FT   STRAND       49     58       {ECO:0000244|PDB:4HDO}.
FT   STRAND       60     62       {ECO:0000244|PDB:4DXA}.
FT   STRAND       63     65       {ECO:0000244|PDB:4M8N}.
FT   HELIX        68     74       {ECO:0000244|PDB:4HDO}.
FT   STRAND       76     83       {ECO:0000244|PDB:4HDO}.
FT   HELIX        87     91       {ECO:0000244|PDB:4HDO}.
FT   HELIX        93    104       {ECO:0000244|PDB:4HDO}.
FT   STRAND      105    107       {ECO:0000244|PDB:3BRW}.
FT   STRAND      111    116       {ECO:0000244|PDB:4HDO}.
FT   HELIX       121    123       {ECO:0000244|PDB:4HDO}.
FT   HELIX       128    137       {ECO:0000244|PDB:4HDO}.
FT   STRAND      142    145       {ECO:0000244|PDB:4HDO}.
FT   TURN        148    151       {ECO:0000244|PDB:4HDO}.
FT   HELIX       154    166       {ECO:0000244|PDB:4HDO}.
SQ   SEQUENCE   184 AA;  20825 MW;  CE976895E5965224 CRC64;
     MREYKLVVLG SGGVGKSALT VQFVQGIFVE KYDPTIEDSY RKQVEVDAQQ CMLEILDTAG
     TEQFTAMRDL YMKNGQGFAL VYSITAQSTF NDLQDLREQI LRVKDTDDVP MILVGNKCDL
     EDERVVGKEQ GQNLARQWNN CAFLESSAKS KINVNEIFYD LVRQINRKTP VPGKARKKSS
     CQLL
//
